Risperidone: all 265 studies that test it
Page 3 of 3. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With SchizophreniaCompletedNCT00240708Phase 3
- A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With SchizophreniaCompletedNCT00236587Phase 3
- Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by InjectionCompletedNCT00236548Phase 3
- A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCompletedNCT00236470Phase 3
- A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236457Phase 3
- A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCompletedNCT00236444Phase 3
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236379Phase 4
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective DisorderCompletedNCT00236353Phase 3
- A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant DependenceCompletedNCT00227123Not applicable
- Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective TrialCompletedNCT00224315Phase 4
- A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)CompletedNCT00216632Phase 4
- The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar ManiaCompletedNCT00216554Phase 4
- A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone MicrospheresCompletedNCT00216528Phase 4
- Risperidone Augmentation for PTSDCompletedNCT00215241Phase 2/3
- A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00210691Phase 3
- A Comparison of Two Standard Therapies in the Management of Dementia With AgitationCompletedNCT00208819Phase 4
- Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape TraumaCompletedNCT00208182Phase 4
- Seroquel Therapy for Substance Use Disorders Comorbid With SchizophreniaCompletedNCT00208143Phase 4
- Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode SchizophreniaCompletedNCT00206960Not applicable
- Risperidone vs. Paroxetine for Panic AttacksTerminatedNCT00206765Phase 2
- Janssen - Glucose Regulation/Risp/OlanzCompletedNCT00205738Not applicable
- Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality DisorderCompletedNCT00204347Phase 4
- Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic InmatesTerminatedNCT00203775Not applicable
- Use of Risperidone in ECT for Treatment Resistant DepressionTerminatedNCT00203723Phase 4
- Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use DisorderCompletedNCT00203528Phase 4
- Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II DisorderCompletedNCT00182013Phase 4
- Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar DisorderCompletedNCT00181935Phase 4
- Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI TreatmentWithdrawnNCT00178854Phase 4
- Treatment of Major Depressive Disorder With Psychotic Features.TerminatedNCT00174590Phase 3
- Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of AntidepressantStatus unknownNCT00174577Phase 3
- Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With RisperidoneCompletedNCT00174200Not applicable
- Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative SymptomsCompletedNCT00169988Not applicable
- A Study of Risperidone Monotherapy in Bipolar AnxietyCompletedNCT00167479Phase 4
- Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)CompletedNCT00166595Phase 1/2
- New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant SchizophreniaCompletedNCT00161018Phase 3
- One Year Drug Treatment in First-Episode SchizophreniaCompletedNCT00159081Phase 4
- Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality DisorderCompletedNCT00158028Not applicable
- Optimization of Acute Treatment in First Episode SchizophreniaStatus unknownNCT00157378Phase 4
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in SchizophreniaCompletedNCT00148083Phase 3
- Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)CompletedNCT00147394Phase 1
- Civilian Post-Traumatic Stress Disorder Risperidone Clinical TrialCompletedNCT00133822Phase 1/2
- The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
- Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I OutpatientsCompletedNCT00097032Phase 3
- Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard TherapyCompletedNCT00095134Phase 3
- A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.CompletedNCT00094926Phase 3
- Investigate Risperidone for the Treatment of Schizophrenia in AdolescentsCompletedNCT00088075Phase 3
- Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.CompletedNCT00086112Phase 3
- Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and AdolescentsCompletedNCT00076115Phase 3
- Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderCompletedNCT00061802Phase 4
- Schizophrenia Study In AdultsCompletedNCT00049946Phase 2
- A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCompletedNCT00044681Phase 3
- CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3
- A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.CompletedNCT00034775Phase 3
- Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's DiseaseCompletedNCT00034762Phase 3
- The Efficacy and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCompletedNCT00034749Phase 3
- Glucose Regulation During Risperidone and Olanzapine TreatmentStatus unknownNCT00006195Not applicable
- Treatment of Autism in Children and AdolescentsCompletedNCT00005014Phase 3
- Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette SyndromeCompletedNCT00004393Phase 2
- Risperidone for Treatment of Cocaine Dependence in Outpatients - 12CompletedNCT00000347Phase 2
- Risperidone for the Treatment of Cocaine Dependence - 7CompletedNCT00000342Phase 2
- Infusion Laboratory: Protocol 3 (Risperidone) - 4Status unknownNCT00000339Phase 1
- Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2TerminatedNCT00000310Phase 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1TerminatedNCT00000309Phase 2
- Risperidone Treatment in Dually-Diagnosed Individuals - 2CompletedNCT00000267Phase 2